Investor Overview
Company Profile
DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments for chronic kidney disease and acute ischemic stroke. DiaMedica's shares are listed on The Nasdaq Capital Market under the trading symbol "DMAC."
-
Go to Detailed Stock Information ›
Nasdaq Stock Snapshot
DMAC
Symbol
Nasdaq
Market
--
Volume
--
Price
--
Change